- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04728191
O efeito da fisioterapia na respiração disfuncional em crianças e adolescentes com e sem asma
O Efeito da Fisioterapia na Respiração Disfuncional em Crianças e Adolescentes com e sem Asma.
The purpose of the study is to investigate the effect of physiotherapeutical instructions on dysfunctional breathing in children and adolescents with or without asthma.
Children and adolescents with dysfunctional breathing, are invited to participate in the intervention study. Participants are stratified by asthma diagnose status and randomized to physiotherapy or standard care. Participants are followed a year after the intervention, to compare the development in asthma control ( if asthma) and quality of life.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The purpose of the study is to investigate the effect of physiotherapeutical instructions on dysfunctional breathing in children and adolescents with or without asthma.
All children and adolescents aged 10-17 years, followed in our outpatient clinic with the diagnose of asthma are invited to fulfill the Nijmegen Questionnaire (NQ) and the Asthma Control Questionnaire (ACQ5)
Children and adolescents where asthma was investigated and ruled out are invited to fulfill the NQ.
Data from the electronic patient journal are used as descriptives.
Participants with dysfunctional breathing (NQ >= 23) are invited to participate in the intervention study. Participants are stratified by asthma diagnose status and randomized to physiotherapy or standard care. Participants are followed a year after the intervention, to compare the development in asthma control measured by ACQ5 (if asthma) and quality of life measured by PedsQL.
The effect of physiotherapy is analyzed separately for participants with and without asthma. In addition, primary outcomes are analyzed in a regression model with asthma status, age and sex as explanatory variables.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Kolding, Dinamarca, 6000
- Signe Vahlkvist
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
Asthma group:
- Asthma diagnosed by lung function tests and/or typical symptoms.
- Treatment with inhaled corticosteroids in minimum 3 months.
- ACQ5 >= 1.5.
- NQ >= 23.
NonAsthma group
- Asthma denied after lung function tests ( exercise challenge or mannitol challenge)
- NQ >= 23.
Exclusion Criteria:
- Other significant cardiopulmonary or muscoluskeletal conditions.
- Complex functional conditions involving other organ systems.
- patients who already had the physotherapeutical intervention before study start.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: + asthma + intervention
35 participants with asthma aged 10-17 years, randomized to physiotherapy. The intervention consists of 4 instruction lessons spread over 6 weeks. The participants are instructed in a daily ten-minute-program of breathing exercizes. |
physiotherapeutical instructions and training as described. |
|
Comparador Ativo: + asthma - intervention
35 participants with asthma aged 10-17 years, randomized to standard care. Participants are getting advice about dysfunctional breathing by a physician or nurse in the outpatient clinic. |
Standard care as described. |
|
Experimental: - asthma + intervention
35 participants without asthma aged 10-17 years, randomized to physiotherapy. The intervention consists of 4 instruction lessons spread over 6 weeks. The participants are instructed in a daily ten-minute-program of breathing exercizes. |
physiotherapeutical instructions and training as described. |
|
Comparador Ativo: - asthma - intervention
35 participants without asthma, which are randomized to standard care. Participants are getting advise about dysfunctional breathing by a physician or nurse in the outpatient clinic. |
Standard care as described. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from baseline in Asthma Control Questionnaire ( ACQ5) at 6 months.
Prazo: ACQ is taken at baseline and 6 months after intervention as primary outcome.
|
ACQ5 contains 5 questions regarding asthma symptoms. Each question is scored between 0-6 points, where 0 represents very good asthma control and 6 represents poor asthma control. Total ACQ score is calculates as an average of points. ACQ5 is taken by participants with asthma, at visits in the outpatient clinic. |
ACQ is taken at baseline and 6 months after intervention as primary outcome.
|
|
Change from baseline in Pediatric Quality of Life Inventory ( PedsQl) at 6 months
Prazo: PedsQL is taken at baseline and 6 months after intervention as primary outcome.
|
PedsQl consists of 23 questions in 4 segments ( physical functioning, emotions, social interaction, and school activities). Each question is scored from 0 (best) to 4 (worst). The PedsQl questionnairre exists in formats for young children ( not used here), children aged 8-12 years and Teenagers aged 13-18 years. Children and adolescents are answering the age relevant questionnairre at visits in the out patient clinic. The PedsQl score is transformed to a 0-100 scale as follows: 0 =100, 1=75, 2=50, 3=25, 4=0. Health related Quality of life is calculated as a mean of scores. Psychosocial Health summary score is calculated as a mean of scores in the emotional, social and school functioning scales. Physical Health summary score is calculated as physical functioning scale score mean. |
PedsQL is taken at baseline and 6 months after intervention as primary outcome.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from baseline in Nijmegen Questionnaire ( NQ)
Prazo: NQ is taken at baseline and 6 weeks, 6 months and 12 months after intervention.
|
NQ consists of 16 questions regarding dysfunctional breathing. Each question is scored between 0-4 points, where 0 is best and 4 is worst. |
NQ is taken at baseline and 6 weeks, 6 months and 12 months after intervention.
|
|
Change from baseline in Brompton breathing Pattern Assesment Tool ( BBPAT)
Prazo: BBPAT is taken at baseline and 6 weeks, 6 months and 12 months after intervention.
|
BBPAT is a breathing scoring equipment where an observer is scoring the quality of breathing from seven parameters including respiratory rate, respiratory movements, in and expiratory sounds etc. Each parameter is scored from 0 ( best) to 2 ( worst). Total score is calculated between 0-14 point |
BBPAT is taken at baseline and 6 weeks, 6 months and 12 months after intervention.
|
|
Number of contacts to the hospital during one year from baseline
Prazo: from baseline to 12 months after intervention.
|
Number of total contacts includes planned visits, extra visits and hospitalisations |
from baseline to 12 months after intervention.
|
|
Change from baseline in Asthma Control Questionnaire ( ACQ5) at 6 weeks and one year. Change from 6 months in ACQ at 12 months.
Prazo: ACQ5 is taken at 6 weeks and 12 months after intervention as secondary outcomes.
|
ACQ5 contains 5 questions regarding asthma symptoms. Each question is scored between 0-6 points, where 0 represents very good asthma control and 6 represents poor asthma control. Total ACQ score is calculates as an average of points. ACQ5 is taken by participants with asthma in the outpatient clinic at baseline and after 6 weeks, 6 months and 12 months. |
ACQ5 is taken at 6 weeks and 12 months after intervention as secondary outcomes.
|
|
Change from baseline in Pediatric Quality of Life Inventory ( PedsQl) at at 6 weeks and one year. Change from 6 months in PedsQl at 12 months.
Prazo: PedsQl is taken at 6 weeks and 12 months after intervention as secondary outcomes.
|
PedsQl consists of 23 questions in 4 segments ( physical functioning, emotions, social interaction, and school activities). Each question is scored from 0 (best) to 4 (worst). The PedsQl questionnairre exists in formats for young children ( not used here), children aged 10-13 years and Teenagers aged 13-18 years. Children and adolescents are answering the age relevant questionnairre at visits in the out patient clinic. The PedsQl score is transformed to a 0-100 scale as follows. 0 =100, 1=75, 2=50, 3=25, 4=0. Health related Quality of life is calculated as mean of scores. Psychosocial Health summary score is calculated as mean of scores in the emotional, social and school functioning scales. Physical Health summary score is calculated physical functioning scale score mean. |
PedsQl is taken at 6 weeks and 12 months after intervention as secondary outcomes.
|
|
The reported use of rescue Beta2 agonist in puffs per week
Prazo: at baseline and 6 weeks, 6 months and 12 months after intervention.
|
The reported use of short acting beta 2 agonist in puffs per week the last week. |
at baseline and 6 weeks, 6 months and 12 months after intervention.
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Signe Vahlkvist, PhD, Kolding Sygehus
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Doenças do sistema imunológico
- Doenças Respiratórias
- Doenças pulmonares
- Doenças brônquicas
- Doenças Pulmonares Obstrutivas
- Hipersensibilidade Respiratória
- Hipersensibilidade, Imediata
- Hipersensibilidade
- Asma
- Administração de Serviços de Saúde
- Qualidade, acesso e avaliação da assistência médica
- Terapêutica
- Qualidade de assistência médica
- Indicadores de qualidade, assistência médica
- Reabilitação
- Padrão de atendimento
- Modalidades de fisioterapia
Outros números de identificação do estudo
- S-20200101-b
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Individual participant data that underlie published results, after deidentification.
Prazo de Compartilhamento de IPD
Beginning 3 months and ending 5 years following article publication.
Critérios de acesso de compartilhamento IPD
Researchers who provide a methodologically sound proposal. Proposals should be directed to Open@rsyd.dk.
Tipo de informação de suporte de compartilhamento de IPD
- SEIVA
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .